(Q34420746)

English

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals (English)

1 reference

Europe PubMed Central

2 August 2017

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

vascular disease

1 reference

based on heuristic

inferred from title

4

object named as

Sarah Parish

1 reference

Europe PubMed Central

2 August 2017

author name string

Borislava Mihaylova

1

1 reference

Europe PubMed Central

2 August 2017

Andrew Briggs

2

1 reference

Europe PubMed Central

2 August 2017

Jane Armitage

3

1 reference

Europe PubMed Central

2 August 2017

Alastair Gray

5

1 reference

Europe PubMed Central

2 August 2017

Rory Collins

6

1 reference

Europe PubMed Central

2 August 2017

Heart Protection Study Collaborative Group

7

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

2 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

2 August 2017

365

1 reference

Europe PubMed Central

2 August 2017

9473

1 reference

Europe PubMed Central

2 August 2017

1779-1785

1 reference

Europe PubMed Central

2 August 2017

randomized experiment

0 references

MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there value in liver function test and creatine phosphokinase monitoring with statin use?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2963014-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(05)63014-0

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34420746&oldid=1945635154"